Hematopoietic-restricted Ptpn11E76K reveals indolent MPN progression in mice

Stefan P. Tarnawsky, Wen Mei Yu, Cheng Kui Qu, Rebecca Chan, Mervin Yoder

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Juvenile Myelomonocytic Leukemia (JMML) is a pediatric myeloproliferative neoplasm (MPN) that has a poor prognosis. Somatic mutations in Ptpn11 are the most frequent cause of JMML and they commonly occur in utero. Animal models of mutant Ptpn11 have probed the signaling pathways that contribute to JMML. However, existing models may inappropriately exacerbate MPN features by relying on nonhematopoietic- restricted Cre-loxP strains or transplantations into irradiated recipients. In this study we generate hematopoietic-restricted models of Ptpn11E76K-mediated disease using Csf1r-MCM and Flt3Cre. We show that these animals have indolent MPN progression despite robust GM-CSF hypersensitivity and Ras-Erk hyperactivation. Rather, the dominant pathology is pronounced thrombocytopenia with expanded extramedullary hematopoiesis. Furthermore, we demonstrate that the timing of tamoxifen administration in Csf1r-MCM mice can specifically induce recombinase activity in either fetal or adult hematopoietic progenitors. We take advantage of this technique to show more rapid monocytosis following Ptpn11E76K expression in fetal progenitors compared with adult progenitors. Finally, we demonstrate that Ptpn11E76K results in the progressive reduction of T cells, most notably of CD4+ and naïve T cells. This corresponds to an increased frequency of T cell progenitors in the thymus and may help explain the occasional emergence of T-cell leukemias in JMML patients. Overall, our study is the first to describe the consequences of hematopoieticrestricted Ptpn11E76K expression in the absence of irradiation. Our techniques can be readily adapted by other researchers studying somatically-acquired blood disorders.

Original languageEnglish (US)
Pages (from-to)21831-21843
Number of pages13
JournalOncotarget
Volume9
Issue number31
DOIs
StatePublished - Apr 24 2018

Fingerprint

Juvenile Myelomonocytic Leukemia
T-Lymphocytes
Neoplasms
Extramedullary Hematopoiesis
T-Cell Leukemia
Recombinases
Tamoxifen
Granulocyte-Macrophage Colony-Stimulating Factor
Thrombocytopenia
Thymus Gland
Hypersensitivity
Animal Models
Transplantation
Research Personnel
Pediatrics
Pathology
Mutation

Keywords

  • JMML
  • Lineage tracing
  • MPN
  • PTPN11

ASJC Scopus subject areas

  • Oncology

Cite this

Hematopoietic-restricted Ptpn11E76K reveals indolent MPN progression in mice. / Tarnawsky, Stefan P.; Yu, Wen Mei; Qu, Cheng Kui; Chan, Rebecca; Yoder, Mervin.

In: Oncotarget, Vol. 9, No. 31, 24.04.2018, p. 21831-21843.

Research output: Contribution to journalArticle

Tarnawsky, Stefan P. ; Yu, Wen Mei ; Qu, Cheng Kui ; Chan, Rebecca ; Yoder, Mervin. / Hematopoietic-restricted Ptpn11E76K reveals indolent MPN progression in mice. In: Oncotarget. 2018 ; Vol. 9, No. 31. pp. 21831-21843.
@article{3ead523a7d8544998805d4a31d1c657b,
title = "Hematopoietic-restricted Ptpn11E76K reveals indolent MPN progression in mice",
abstract = "Juvenile Myelomonocytic Leukemia (JMML) is a pediatric myeloproliferative neoplasm (MPN) that has a poor prognosis. Somatic mutations in Ptpn11 are the most frequent cause of JMML and they commonly occur in utero. Animal models of mutant Ptpn11 have probed the signaling pathways that contribute to JMML. However, existing models may inappropriately exacerbate MPN features by relying on nonhematopoietic- restricted Cre-loxP strains or transplantations into irradiated recipients. In this study we generate hematopoietic-restricted models of Ptpn11E76K-mediated disease using Csf1r-MCM and Flt3Cre. We show that these animals have indolent MPN progression despite robust GM-CSF hypersensitivity and Ras-Erk hyperactivation. Rather, the dominant pathology is pronounced thrombocytopenia with expanded extramedullary hematopoiesis. Furthermore, we demonstrate that the timing of tamoxifen administration in Csf1r-MCM mice can specifically induce recombinase activity in either fetal or adult hematopoietic progenitors. We take advantage of this technique to show more rapid monocytosis following Ptpn11E76K expression in fetal progenitors compared with adult progenitors. Finally, we demonstrate that Ptpn11E76K results in the progressive reduction of T cells, most notably of CD4+ and na{\"i}ve T cells. This corresponds to an increased frequency of T cell progenitors in the thymus and may help explain the occasional emergence of T-cell leukemias in JMML patients. Overall, our study is the first to describe the consequences of hematopoieticrestricted Ptpn11E76K expression in the absence of irradiation. Our techniques can be readily adapted by other researchers studying somatically-acquired blood disorders.",
keywords = "JMML, Lineage tracing, MPN, PTPN11",
author = "Tarnawsky, {Stefan P.} and Yu, {Wen Mei} and Qu, {Cheng Kui} and Rebecca Chan and Mervin Yoder",
year = "2018",
month = "4",
day = "24",
doi = "10.18632/oncotarget.25073",
language = "English (US)",
volume = "9",
pages = "21831--21843",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "31",

}

TY - JOUR

T1 - Hematopoietic-restricted Ptpn11E76K reveals indolent MPN progression in mice

AU - Tarnawsky, Stefan P.

AU - Yu, Wen Mei

AU - Qu, Cheng Kui

AU - Chan, Rebecca

AU - Yoder, Mervin

PY - 2018/4/24

Y1 - 2018/4/24

N2 - Juvenile Myelomonocytic Leukemia (JMML) is a pediatric myeloproliferative neoplasm (MPN) that has a poor prognosis. Somatic mutations in Ptpn11 are the most frequent cause of JMML and they commonly occur in utero. Animal models of mutant Ptpn11 have probed the signaling pathways that contribute to JMML. However, existing models may inappropriately exacerbate MPN features by relying on nonhematopoietic- restricted Cre-loxP strains or transplantations into irradiated recipients. In this study we generate hematopoietic-restricted models of Ptpn11E76K-mediated disease using Csf1r-MCM and Flt3Cre. We show that these animals have indolent MPN progression despite robust GM-CSF hypersensitivity and Ras-Erk hyperactivation. Rather, the dominant pathology is pronounced thrombocytopenia with expanded extramedullary hematopoiesis. Furthermore, we demonstrate that the timing of tamoxifen administration in Csf1r-MCM mice can specifically induce recombinase activity in either fetal or adult hematopoietic progenitors. We take advantage of this technique to show more rapid monocytosis following Ptpn11E76K expression in fetal progenitors compared with adult progenitors. Finally, we demonstrate that Ptpn11E76K results in the progressive reduction of T cells, most notably of CD4+ and naïve T cells. This corresponds to an increased frequency of T cell progenitors in the thymus and may help explain the occasional emergence of T-cell leukemias in JMML patients. Overall, our study is the first to describe the consequences of hematopoieticrestricted Ptpn11E76K expression in the absence of irradiation. Our techniques can be readily adapted by other researchers studying somatically-acquired blood disorders.

AB - Juvenile Myelomonocytic Leukemia (JMML) is a pediatric myeloproliferative neoplasm (MPN) that has a poor prognosis. Somatic mutations in Ptpn11 are the most frequent cause of JMML and they commonly occur in utero. Animal models of mutant Ptpn11 have probed the signaling pathways that contribute to JMML. However, existing models may inappropriately exacerbate MPN features by relying on nonhematopoietic- restricted Cre-loxP strains or transplantations into irradiated recipients. In this study we generate hematopoietic-restricted models of Ptpn11E76K-mediated disease using Csf1r-MCM and Flt3Cre. We show that these animals have indolent MPN progression despite robust GM-CSF hypersensitivity and Ras-Erk hyperactivation. Rather, the dominant pathology is pronounced thrombocytopenia with expanded extramedullary hematopoiesis. Furthermore, we demonstrate that the timing of tamoxifen administration in Csf1r-MCM mice can specifically induce recombinase activity in either fetal or adult hematopoietic progenitors. We take advantage of this technique to show more rapid monocytosis following Ptpn11E76K expression in fetal progenitors compared with adult progenitors. Finally, we demonstrate that Ptpn11E76K results in the progressive reduction of T cells, most notably of CD4+ and naïve T cells. This corresponds to an increased frequency of T cell progenitors in the thymus and may help explain the occasional emergence of T-cell leukemias in JMML patients. Overall, our study is the first to describe the consequences of hematopoieticrestricted Ptpn11E76K expression in the absence of irradiation. Our techniques can be readily adapted by other researchers studying somatically-acquired blood disorders.

KW - JMML

KW - Lineage tracing

KW - MPN

KW - PTPN11

UR - http://www.scopus.com/inward/record.url?scp=85045885888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045885888&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.25073

DO - 10.18632/oncotarget.25073

M3 - Article

AN - SCOPUS:85045885888

VL - 9

SP - 21831

EP - 21843

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 31

ER -